BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32370989)

  • 1. The expression of ribonuclear protein IMP3 in laryngeal carcinogenesis.
    Maržić D; Čoklo M; Marijić B; Hadžisejdić I; Dekanić A; Krstulja M; Šepić T; Avirović M; Braut T
    Pathol Res Pract; 2020 Jun; 216(6):152974. PubMed ID: 32370989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of vocal cord polyps applying markers of squamous cell carcinogenesis.
    Braut T; Krstulja M; Marijić B; Maržić D; Kujundžić M; Brumini G; Vučinić D; Oštarijaš E
    Pathol Res Pract; 2019 Jan; 215(1):144-150. PubMed ID: 30455127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma.
    Chen K; Cornejo KM; Ye W; Wu Q; Liang J; Jiang Z
    Hum Pathol; 2013 Oct; 44(10):2126-31. PubMed ID: 23806529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMP3 Protein Overexpression Is Linked to Unfavorable Outcome in Laryngeal Squamous Cell Carcinoma.
    Maržić D; Marijić B; Braut T; Janik S; Avirović M; Hadžisejdić I; Tudor F; Radobuljac K; Čoklo M; Erovic BM
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
    Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
    Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of Cyclin D1, FGF3 and p21 protein expression in laryngeal squamous cell carcinoma.
    Jovanovic IP; Radosavljevic GD; Simovic-Markovic BJ; Stojanovic SP; Stefanovic SM; Pejnovic NN; Arsenijevic NN
    J BUON; 2014; 19(4):944-52. PubMed ID: 25536600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.
    Wachters JE; Kop E; Slagter-Menkema L; Mastik M; van der Wal JE; van der Vegt B; de Bock GH; van der Laan BFAM; Schuuring E
    Laryngoscope; 2020 Dec; 130(12):2825-2832. PubMed ID: 32065407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of α-smooth muscle actin in confirming the microinvasion of laryngeal squamous cell carcinoma.
    Bai Y; Yue C; Lu Z; Li P; Liu H
    Ann Diagn Pathol; 2021 Oct; 54():151804. PubMed ID: 34419855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G1/S-specific cyclin-D1 might be a prognostic biomarker for patients with laryngeal squamous cell carcinoma.
    Zhang YY; Xu ZN; Wang JX; Wei DM; Pan XL
    Asian Pac J Cancer Prev; 2012; 13(5):2133-7. PubMed ID: 22901182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated neutrophil-to-lymphocyte ratio in squamous cell carcinoma of larynx compared to benign and precancerous laryngeal lesions.
    Kum RO; Ozcan M; Baklaci D; Kum NY; Yilmaz YF; Gungor V; Unal A
    Asian Pac J Cancer Prev; 2014; 15(17):7351-5. PubMed ID: 25227841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.
    Karamagkiolas S; Giotakis I; Kyrodimos E; Giotakis EI; Kataki A; Karagianni F; Lazaris AM
    Am J Otolaryngol; 2019; 40(4):487-493. PubMed ID: 30979652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of cyclin G1 in laryngeal squamous cell carcinoma and its clinicopathologic significance].
    Cui XF; Liu AJ; Wei LX; Chen XG
    Zhonghua Bing Li Xue Za Zhi; 2008 Mar; 37(3):165-8. PubMed ID: 18788592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between levels of expression of minichromosome maintenance proteins, Ki-67 proliferation antigen and metallothionein I/II in laryngeal squamous cell cancer.
    Nowinska K; Chmielewska M; Piotrowska A; Pula B; Pastuszewski W; Krecicki T; Podhorska-Okołow M; Zabel M; Dziegiel P
    Int J Oncol; 2016 Feb; 48(2):635-45. PubMed ID: 26648405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of p27(kip1) in metastatic laryngeal squamous cell carcinoma.
    Bodnar M; Szylberg Ł; Kaźmierczak W; Marszałek A
    Adv Med Sci; 2014 Sep; 59(2):206-12. PubMed ID: 25323759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma.
    Zhou G; Zhang S; Jin M; Hu S
    BMC Cancer; 2022 Jun; 22(1):667. PubMed ID: 35715770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrement of prognostic nutrition index in laryngeal diseases: from precancerous lesion to squamous cell carcinoma.
    Daquan W; Tian W; Shen N; Danzheng L; Xinsheng H
    Acta Otolaryngol; 2021 Dec; 141(12):1070-1074. PubMed ID: 34823427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aberrant expression of CyclinE and p27 in laryngeal squamous cell carcinoma and the clinical significance].
    Chai D; Bao Z; Hu J; Ma L; Feng Z; Tao Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(3):165-9, 174. PubMed ID: 24826452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.
    Liu Y; Zhou YD; Xiao YL; Li MH; Wang Y; Kan X; Li QY; Lu JG; Jin DJ
    Asian Pac J Cancer Prev; 2015; 16(7):2659-64. PubMed ID: 25854342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch1 overexpression associates with poor prognosis in human laryngeal squamous cell carcinoma.
    Li D; Dong P; Wu C; Cao P; Zhou L
    Ann Otol Rhinol Laryngol; 2014 Oct; 123(10):705-10. PubMed ID: 24789803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Cell Cycle-related Proteins p16, p27 and Ki-67 Proliferating Marker in Laryngeal Squamous Cell Carcinomas and in Laryngeal Papillomas.
    Ciesielska U; Zatonski T; Nowinska K; Ratajczak-Wielgomas K; Grzegrzolka J; Piotrowska A; Olbromski M; Pula B; Podhorska-Okolow M; Dziegiel P
    Anticancer Res; 2017 May; 37(5):2407-2415. PubMed ID: 28476808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.